back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 15:31 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,162 vol |
96,388 | |
| Filed 2024-06-18 15:42 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,472 vol |
64,226 | |
| Filed 2023-06-26 12:38 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,997
+12,787 vol $3.91 each |
12,787 | |
| Filed 2023-06-26 12:38 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-05 16:55 Tx date 2023-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+16,968 vol |
35,754 | |
| Filed 2021-07-23 20:46 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$68,381
+18,786 vol $3.64 each |
18,786 | |
| Filed 2021-07-23 20:45 Tx date 2021-07-15 |
$DMAC
DiaMedica Therapeutics Inc. |
Semba, Charles
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|